Labcorp Holdings Inc. ( LH) - Key Metrics
LH Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $45.67 | $3.66 | $5.45 | $3.84 |
| 2026Q1 | $42.98 | $3.38 | $2.33 | $0.86 |
| 2025Q4 | $42.62 | $2 | $7.44 | $5.94 |
| 2025Q3 | $42.88 | $3.14 | $4.66 | $3.38 |
| 2025Q2 | $42.24 | $2.85 | $7.43 | $6.50 |
LH Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 19.65% | 19.13 |
| 2026Q1 | 22.03% | 19.79 |
| 2025Q4 | 36.00% | 31.36 |
| 2025Q3 | 22.94% | 22.86 |
| 2025Q2 | 25.18% | 22.95 |
LH Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 1.37% | 0.26% |
| 2026Q1 | 0.32% | 0.28% |
| 2025Q4 | 2.37% | 0.29% |
| 2025Q3 | 1.18% | 0.25% |
| 2025Q2 | 2.48% | 0.27% |
LH
Price: $326.89
Dividend Yield: 0.94%
Forward Dividend Yield: 0.88%
Payout Ratio: 53.43%
Dividend Per Share: 2.88 USD
Earnings Per Share: 12.27 USD
P/E Ratio: 25.46
Exchange: NYQ
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Volume: 347600
Ebitda: 501.8 millionMarket Capitalization: 25.3 billion
Average Dividend Frequency: 4
Years Paying Dividends: 5
DGR3: 30.00%